WO2006033912A3 - Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette - Google Patents
Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette Download PDFInfo
- Publication number
- WO2006033912A3 WO2006033912A3 PCT/US2005/032706 US2005032706W WO2006033912A3 WO 2006033912 A3 WO2006033912 A3 WO 2006033912A3 US 2005032706 W US2005032706 W US 2005032706W WO 2006033912 A3 WO2006033912 A3 WO 2006033912A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- bone disorders
- anabolic drugs
- skeletal anabolic
- skeletal
- Prior art date
Links
- 208000020084 Bone disease Diseases 0.000 title 1
- 230000001195 anabolic effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 108700020797 Parathyroid Hormone-Related Proteins 0.000 abstract 1
- 102000043299 Parathyroid hormone-related Human genes 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007532415A JP2008513459A (ja) | 2004-09-16 | 2005-09-14 | 骨同化物質を用いた骨疾患の治療方法 |
MX2007003185A MX2007003185A (es) | 2004-09-16 | 2005-09-14 | Tratamiento de trastornos oseos con farmacos anabolicos esqueletales. |
CA002580281A CA2580281A1 (fr) | 2004-09-16 | 2005-09-14 | Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette |
AU2005287139A AU2005287139A1 (en) | 2004-09-16 | 2005-09-14 | Treatment of bone disorders with skeletal anabolic drugs |
EP05797693A EP1799240A4 (fr) | 2004-09-16 | 2005-09-14 | Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61028304P | 2004-09-16 | 2004-09-16 | |
US60/610,283 | 2004-09-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006033912A2 WO2006033912A2 (fr) | 2006-03-30 |
WO2006033912A3 true WO2006033912A3 (fr) | 2006-06-29 |
WO2006033912B1 WO2006033912B1 (fr) | 2006-09-08 |
Family
ID=36090476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/032706 WO2006033912A2 (fr) | 2004-09-16 | 2005-09-14 | Traitement des affections osseuses a l'aide de medicaments anabolisants du squelette |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1799240A4 (fr) |
JP (1) | JP2008513459A (fr) |
AU (1) | AU2005287139A1 (fr) |
CA (1) | CA2580281A1 (fr) |
MX (1) | MX2007003185A (fr) |
WO (1) | WO2006033912A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2506274C2 (ru) | 2007-08-01 | 2014-02-10 | Дзе Дженерал Хоспитал Корпорейшн | Способы скрининга с применением g-белок сопряженных рецепторов и родственных композиций |
EP2509996A1 (fr) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Hormone parathyroïde de l'ours noir et ses procédés d'utilisation |
EP2569003B1 (fr) | 2010-05-13 | 2017-10-25 | The General Hospital Corporation | Analogues de l'hormone parathyroïdienne et leurs utilisations |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030171288A1 (en) * | 2002-01-10 | 2003-09-11 | Stewart Andrew F. | Treatment of bone disorders with skeletal anabolic drugs |
WO2003099849A2 (fr) * | 2002-05-23 | 2003-12-04 | Michael Holick | Utilisation d'analogues peptidiques d'hormone parathyroide pour le traitement de l'atrophie vaginale |
-
2005
- 2005-09-14 CA CA002580281A patent/CA2580281A1/fr not_active Abandoned
- 2005-09-14 AU AU2005287139A patent/AU2005287139A1/en not_active Abandoned
- 2005-09-14 WO PCT/US2005/032706 patent/WO2006033912A2/fr active Application Filing
- 2005-09-14 MX MX2007003185A patent/MX2007003185A/es not_active Application Discontinuation
- 2005-09-14 JP JP2007532415A patent/JP2008513459A/ja active Pending
- 2005-09-14 EP EP05797693A patent/EP1799240A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030171288A1 (en) * | 2002-01-10 | 2003-09-11 | Stewart Andrew F. | Treatment of bone disorders with skeletal anabolic drugs |
WO2003099849A2 (fr) * | 2002-05-23 | 2003-12-04 | Michael Holick | Utilisation d'analogues peptidiques d'hormone parathyroide pour le traitement de l'atrophie vaginale |
Non-Patent Citations (1)
Title |
---|
See also references of EP1799240A4 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006033912A2 (fr) | 2006-03-30 |
EP1799240A4 (fr) | 2009-07-22 |
EP1799240A2 (fr) | 2007-06-27 |
CA2580281A1 (fr) | 2006-03-30 |
WO2006033912B1 (fr) | 2006-09-08 |
MX2007003185A (es) | 2007-10-16 |
JP2008513459A (ja) | 2008-05-01 |
AU2005287139A1 (en) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003059291A3 (fr) | Traitement des affections osseuses avec des medicaments anabolisants du squelette | |
TW200612892A (en) | Novel compounds | |
WO2005046603A3 (fr) | Composes pyridiniques | |
WO2007092065A3 (fr) | Composés et compositions servant de modulateurs du lxr | |
WO2005105110A3 (fr) | Analogues de doxepine et leurs procedes d'utilisation | |
WO2006047516A3 (fr) | Composes et compositions servant d'inhibiteurs d'activite de recepteur cannabinoide de type 1 | |
WO2006015259A3 (fr) | Composes et compositions comme modulateurs de recepteurs steroides | |
TW200630336A (en) | Novel compounds | |
TW200621690A (en) | Novel compounds | |
WO2010045258A3 (fr) | Modulateurs spirocycliques de gpr40 | |
WO2008076754A3 (fr) | Composés et compositions utilisés comme inhibiteurs de l'activité du récepteur cannabinoïde 1 | |
WO2002100347A3 (fr) | Promedicaments d'analogues de gaba, compositions et utilisations desdits promedicaments | |
TW200505837A (en) | Novel compounds | |
TW200519075A (en) | Novel compounds | |
WO2008097428A3 (fr) | Composés et compositions tels que des modulateurs d'une activité gpr119 | |
WO2007120689A3 (fr) | Procédés d'utilisation du récepteur gpr119 pour identifier des composés utiles pour augmenter la masse osseuse chez un individu | |
WO2008063867A3 (fr) | Composés tétrahydrocyclopenta[b] indole comme modulateurs du récepteur des androgènes | |
WO2008137787A3 (fr) | Thérapie de combinaison avec un composé agissant comme inhibiteur de récepteur à l'adp de plaquettes | |
WO2005077122A3 (fr) | Composes et compositions convenant comme modulateurs des lxr | |
WO2007111994A3 (fr) | Composés et méthodes pour traitement de troubles associés à un stress du réticulum endoplasmique | |
TW200732296A (en) | Novel compounds | |
WO2005086656A3 (fr) | Derives d'heteroarylaminopyrazole utilises pour traiter le diabete | |
WO2006066011A3 (fr) | Composes et compositions utilises comme modulateurs de recepteurs steroidiens et d'activites du canal calcium | |
WO2006036813A3 (fr) | Composes de vitamine d3 sous forme de 20-cycloalkyl,26,27-alkyl/haloalkyle et leurs procedes d'utilisation | |
WO2005092062A3 (fr) | Composes destines aux troubles neurodegeneratifs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2580281 Country of ref document: CA Ref document number: 2005287139 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/003185 Country of ref document: MX Ref document number: 2007532415 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005287139 Country of ref document: AU Date of ref document: 20050914 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005287139 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1236/KOLNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005797693 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005797693 Country of ref document: EP |